MTOR and hepatocellular carcinoma: IL-37, an anti-inflammatory and antineoplastic cytokine, blocking the effects of IL-1α/β and IL-18, thereby inducing the autophagia and facilitating hepatocytes apoptosis in HCC through inhibiting the PI3K/Akt/mTOR signaling pathway (104).